UCD

About

UCD is one of Europe’s leading research-intensive universities; an environment where undergraduate education, masters and PhD training, research, innovation and community engagement form a dynamic spectrum of activity. Since its foundation, the University has made a unique contribution to the creation of modern Ireland, based on successful engagement with Irish society on every level and across every sphere of activity.

The international standing of UCD has grown in recent years; it is currently ranked within the top 1% of higher education institutions world-wide. UCD is also Ireland’s most globally engaged university with over 38,000 students drawn from 152 countries, including over 5,000 students based at locations outside of Ireland. As Ireland’s largest university, with its great strength and diversity of disciplines, UCD embraces its role to contribute to the flourishing of Ireland through the study of people, society, business, economy, culture, languages and the creative arts, as well as through research and innovation.

The School of Biomolecular and Biomedical Science (SBBS) hosts staff from the disciplines of microbiology, biochemistry, pharmacology, genetics and neuroscience. The school is highly research intensive and special emphasis is placed on translating fundamental discoveries to applications.

The diversity of expertise ranges from structural biology to biomedicine to biotechnology. This varied environment is a major facilitator for interdisciplinary scholarship and research and provides the school with a unique forum to investigate biological systems at molecular, cellular and whole-organism levels.

Role in Upcycle

UCD will be involved in WP3, focusing on strain and process engineering. In WP3.1, UCD will aim to improve the production of PHAs from PET/PBAT hydrolysates through the engineering of production pathways.

In WP3.4, UCD will further engineer FDCA producing strains for efficient production of the bioplastic monomer when the cells are grown on PET monomers. These results will be tested in bioreactors and used to achieve tech transfer to 5 L and culminating in 100 L scales in WP3.6.